Stewart, Grant D. http://orcid.org/0000-0003-3188-9140
Welsh, Sarah J.
Ursprung, Stephan
Gallagher, Ferdia A. http://orcid.org/0000-0003-4784-5230
Jones, James O.
Shields, Jacqui
Smith, Christopher G. http://orcid.org/0000-0001-7357-2737
Mitchell, Thomas J.
Warren, Anne Y.
Bex, Axel
Boleti, Ekaterini
Carruthers, Jade
Eisen, Tim
Fife, Kate
Hamid, Abdel
Laird, Alexander
Leung, Steve
Malik, Jahangeer
Mendichovszky, Iosif A.
Mumtaz, Faiz
Oades, Grenville
Priest, Andrew N.
Riddick, Antony C. P.
Venugopal, Balaji
Welsh, Michelle
Riddle, Kathleen
Hopcroft, Lisa E. M.
Couper, Niki
Hopcroft, Lisa E. M.
Hill, Robert
Matakidou, Athena
Caasi, Cara
Watson, James
Wallis, Lauren
Cross, Ruby
Burge, Sarah W.
George, Anne
Klatte, Tobias
Aho, Tevita F.
Armitage, James N.
Rossi, Sabrina
Massie, Charlie
Anand, Shubha
Haddow, Tiffany
Dodd, Marc
Deng, Wenhan
Martin, Ezequiel
Howden, Philip
Wenlock, Stephanie
Sala, Evis
Symeonides, Stefan
Ho, Lynn
Baxter, Jennifer
Leslie, Stuart
McLaren, Duncan
Brush, John
O’Donnell, Marie
Griffin, Alisa
Orr, Ruth
Cowan, Catriona
Powles, Thomas
Pejnovic, Anna
Tincey, Sophia
Grant, Lee
Nuttall, Martin
Willsher, Lucy
Barnett, Christian
Nicol, David
Larkin, James
Fielding, Alison
Jones, Robert J. http://orcid.org/0000-0002-2904-6980
,
Funding for this research was provided by:
Cancer Research UK (A23471)
Article History
Received: 14 March 2022
Revised: 25 May 2022
Accepted: 1 June 2022
First Online: 23 June 2022
Ethics approval and consent to participate
: Ethics approval was granted by the East of England—Cambridgeshire and Hertfordshire Research Ethics Committee (REC reference: 17/EE/0240). All patients were consented to following GCP principles. The study was performed in accordance with the Declaration of Helsinki.
: Consent for publication of imaging (Supplementary Fig. InternalRef removed) is provided via a trial consent form.
: GDS—educational grants from Pfizer, AstraZeneca and Intuitive Surgical; consultancy fees from Pfizer, Merck, EUSA Pharma and CMR Surgical; Travel expenses from Pfizer and Speaker fees from Pfizer. TE—employment: Roche (current), AstraZeneca (to March 2020); stock: AstraZeneca, Roche; research support: AstraZeneca, Bayer, Pfizer. FAG—research support from GE Healthcare; Grants from GSK; Consulting for AZ on behalf of the University of Cambridge. KF has received advisory, consultancy or speaker fees from ESAI, Ipsen, Roche, Novartis, Merck, Pfizer, EUSA Pharma, BMS, MSD and Sanofi and conference support from Novartis, Ipsen, MSD and EUSA Pharma and Institutional research funding from Roche, Merck and Exelixis. AB received honoraria for participation in advisory boards for Pfizer, Novartis, and Ipsen, and an educational grant from Pfizer. RJ has received educational grants from Astellas, Bayer, Clovis and Exelixis; consultancy fees from Roche, AstraZeneca, Bristol Myers Squibb, Bayer, Novartis/AAA, Astellas, Janssen, MSD, Pfizer, Merck Serono; honoraria from Roche, AstraZeneca, Bristol Myers Squibb, Bayer, Astellas, Janssen, MSD, Pfizer, Merck Serono; conference support from MSD and Bayer; advisory board payment from Roche. The remaining authors declare no competing interests.